UPDATE: PerkinElmer Revenues Climb 14 Percent in Second Quarter | GenomeWeb

The article has been updated to provide additional information.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – PerkinElmer reported after the close of the market Thursday that revenues for the second quarter climbed nearly 14 percent, outpacing consensus analyst estimates.

In the three months ended July 4, the company posted revenues of $497.8 million, up from $438.3 million a year ago. Wall Street had expected revenues of $464.7 million for the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.